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The chemical nature of the sensitizer and its selective uptake by malignant cells are decisive to choose an appropriate biocompatible carrier,
able to preserve the photosensitizing characteristics of the dye. In this paper we demonstrate the photodynamic properties of three chlorins, derived
from chlorophyll a, and the usefulness of liposomal carriers to design pharmaceutical formulations. The chlorins have been quantitatively
incorporated into stable liposomes obtained from a mixture of L-α-palmitoyloleoylphosphatidylcholine and L-α-dioleoylphosphatidylserine in a
13.5:1.5 molar ratio (POPC/OOPS-liposomes). The chlorin uptake by skin fibroblasts increases steadily, reaching in all cases a plateau level
dependent on both the chlorin structure and the vehicle employed. The photophysical properties of the three chlorins in THF are nearly identical
and fulfill the requirements for a PDT photosensitizer. Incorporation of chlorins into liposomes induces important changes in their photophysics,
but does not impair their cellular uptake or their cell photosensitization ability. In fact we observe in the cells the same photophysical behavior as
in THF solution. Specifically, we demonstrate, by recording the near-IR phosphorescence of 1O2, that the chlorins are able to photosensitize the
production of 1O2 in the cell membrane. The cell-photosensitization efficiency depended on the chlorin and cell line nature, the carrier, and the
length of pre-incubation and post-irradiation periods. The high photodynamic activity of chlorin-loaded liposomes and the possibility to design
liposomal carriers to achieve a specific target site favors this approach to obtain an eventual pharmaceutical formulation.
© 2006 Elsevier B.V. All rights reserved.Keywords: Photosensitizers; Fluorescence lifetime; Photocytotoxicity; Singlet oxygen; Fibroblasts; HeLa cells1. Introduction
The therapeutic properties of light have been employed in the
treatment of disease for more than three thousand years.Abbreviations: CHL-1, 3-Phorbinepropanol, 9,14-diethyl-4,8,13,18-tetra-
methyl-20-(3S-trans); CHL-2, 3-Phorbinepropanoic acid, 9,14-diethyl-
4,8,13,18-tetramethyl-20-(3S-trans) (meso-pyropheophorbide a); CHL-3, 3-
Methyl-phorbinepropanoate, 9,14-diethyl-4,8,13,18-tetramethyl-20-(3S-trans)
(meso-pyropheophorbide amethyl ester); DMEM, Dulbecco'sModified Eagle's
Medium; DMPC, L-α-dimiristoylphospatidylcholine; DPPC, L-α-dipalmitoyl-
phosphatidylcholine; DMSO, dimethylsulfoxide; MB, methylene blue; MTT,
3-[4,5-dimethylthiazol-2-yl] 2,5-diphenyltetrazolium bromide; OOPS, L-α-
dioleoylphosphatidylserine; PBS, Phosphate Buffered Saline; POPC, L-α-
palmitoleoylphospathidylcholine; THF, tetrahydrofuran; TPP, 5,10,15,20-tetra-
phenyl-21H,23H-porphine; TPPS, 5,10,15,20-tetrakis(4-sulfonato)phenyl-21H,
23H-porphine
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doi:10.1016/j.bbamem.2006.02.027Nevertheless, the exploitation of their benefits in medicine
comes about the last century with the development of
photodynamic therapy (PDT) [1–3]. Photodynamic therapy
involves the administration of a photosensitizing agent,
followed by irradiation with visible non-thermal light (400–
760 nm) to produce a series of cascade events eventually
leading to the generation of reactive oxygen species. It may be
employed in clinical oncology [4,5] for the treatment of other
non-malignant conditions and many kind of skin afflictions [6–
10], for virus inactivation [11], and for bactericidal purposes
[12]. Besides these applications, drugs structurally related to
photosensitizing agents are used in the detection of tumors by
magnetic resonance imaging (MRI) [13,14].
Photodamage in PDT is described to occur by the so-called
type I and type II mechanisms [15,16], depending on the kind of
reaction undergone by the sensitizer after absorption of light.
The electronically-excited state thus generated can react directly
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reaction). Alternatively, it can transfer its energy to an oxygen
molecule to form singlet oxygen (1O2), an electronically-
excited, non-radical form of molecular oxygen (type II
reaction). 1O2 is highly reactive towards proteins, lipids, and
nucleic acids, thus initiating oxidation chains that ultimately
lead to the destruction of cells [4,5,15]. Formation of 1O2 under
photodynamic conditions has been demonstrated in vitro and in
vivo [17].
The most efficiently-excited sensitizers are those which have
strong absorption bands at the red end of the visible spectrum
[18]. After the first-generation photosensitizer porfimer sodium
received the approval by regulatory authorities, it became
evident that there was a need for new compounds with
improved photochemical properties and less side effects.
Thus, a second-generation of photosensitizers with higher
absorption coefficients in the 600–800 nm region and high
quantum yields of singlet oxygen formation has been developed
[11]. The compounds that have been more actively investigated
include porphyrins, phthalocyanines, chlorins and bacterio-
chlorins, texaphyrins, and porphycenes [18]. Among them,
chlorin derivatives, which differ from porphyrins only by
saturation of a peripheral double bond of the macrocycle, are
receiving considerable attention as potential drugs for photo-
dynamic therapy. They have a considerable absorption in the so-
called therapeutic window (650–900 nm), a fairly good triplet
yield and show good tumor selectivity [19–21]. Nyman and
Hynninen [22] have recently published an exhaustive review
about the most recent advances in PDT, which considers the
features and sources of different chlorins.
The efficacy of PDT is also determined by the selective
localization of the photosensitizer in the malignant cells.
Current trends focus on the development of the so-called
third-generation photosensitizers [18], which are elaborated
molecules, obtained from second generation compounds, with
improved targeting mechanisms. This goal is achieved by
incorporation into or attachment to chemical devices, e.g. by
conjugation to monoclonal antibodies [23], by integration in the
lipid bilayers of colloidal carriers such as liposomes [24], or by
spatially isolation by an ionic dendrimer framework [25].
On the other hand, the most potent sensitizers are those
that localize in photosensitive cellular compartments, partic-
ularly cell membranes where hydrophobic or amphiphilic
sensitizers tend to accumulate. While hydrophobicity is an
advantageous feature for PDT efficiency, it poses serious
difficulties for drug administration through the blood stream,
since hydrophobic sensitizers tend to aggregate in polar
environments. Moreover, this aggregation results in a
deterioration of the photophysical properties of photosensi-
tizers, decreasing the photo-oxidation efficacy desired in
photodynamic therapy [25]. This problem can be overcome
by formulating the photosensitizers into suitable carriers,
providing a biocompatible environment. For the purpose of
in vitro studies but not for clinical applications, an expedient
alternative is to solubilize the photosensitizer in organic
solvent–water mixtures. DMSO is quite often the solvent of
choice.These considerations have pointed out the need for advanced
delivery systems for PDT [26,27] and that both the sensitizer
and the vehicle determine its efficacy [28,29]. There is an
extensive literature about the use of drug delivery systems in the
therapeutic treatments of many diseases [30]. It has been
demonstrated that many of the pharmacological properties of
conventional-free drugs can be improved through the use of
drug delivery systems, which include polymer carriers,
liposomes and bioconjugates [25,31,32]. Drug delivery systems
are able to modify the pharmacokinetics and biodistribution of
their associated drugs or to act as drug reservoirs. In this way,
liposomes are especially useful carriers in the therapy of many
diseases. In photodynamic therapy, it has been shown that
liposomes increase the photosensitizing efficiency of some PDT
agents by maintaining their monomeric form, by having a
concentration effect, by modifying the uptake of the dye by
malignant cells, or by influencing their subcellular location
[33,34]. Indeed, Lavi et al. [35] have demonstrated the
enhancement of the photosensitization process when the
photosensitizer inserts their tetrapyrrole chromophore deeper
into the liposomal lipid bilayer and the important effect of
fluidization of the bilayer on the resulting photosensitization
efficiency. Hydrophobic and amphiphilic photosensitizers
entrapped into liposomes increase and sustain their clinical
effects, reduce their toxicity, and are more protected from
metabolism and immune responses [36]. Because of this,
liposomes are considered valuable carriers to enhance the
clinical effects of photodynamic treatments [37–39]. Different
approaches to the design of liposomal carriers have been
reported [40]. Passive versus active targeting or conventional
versus surface-modified vesicles are criterions of choice to
develop appropriate drug carriers for specific applications.
Moreover, the carrier should ideally be able to incorporate the
photosensitizer without loss or alteration of its activity. In this
way, we have reported the lipid composition, method of
liposome preparation, and structural features of photosensitizers
for optimal incorporation into stable lipid vesicles. Special
efforts have been devoted to prevent sensitizer aggregation in
the lipid bilayer, since the ability of the liposome to solubilize
the photosensitizer is dramatically decreased when it forms
aggregates [41]. In addition, it has also been reported that only
monomeric species and possibly planar end-to-end aggregates
are endowed with significant photosensitizing ability [42].
Besides these remarks, it is of great interest in the field of
anticancer therapy the consideration of the sensitivity of
different cell lines to PDT. Thus, it seems that the effect of
PDT depends on the sensitizer employed, but also on the cell
type treated [43,44]. Zhang et al. [45] have shown that HeLa
cells (a cervical adenocarcinoma cell line) are less sensitive to
hypocrellin-A PDT than HIC (human intestinal cancer) and
MGC-803 (mucoid gastric cancer) cells. Ahn et al. [46] also
reported the effectiveness of PDT with the photosensitizing
agent Photogem® against HeLa cells and pointed out that it
might constitute an alternative to chemo- and radiotherapy,
knowing the resistance of this type of tumor to these treatments.
On the other hand, Tong et al. [47] have shown that at
equivalent cellular Photofrin levels, Li–Fraumeni syndrome
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fibroblasts to photofrin-mediated PDT, despite the fact that
the uptake of photofrin per cell was greater in human fibroblasts
cells than in LFS cells. In addition, different photodynamic
effects of 5-aminolevulinic acid on neuroblastoma, hepatoma
and fibroblast cells have also been reported [48]. The greatest
sensitivity of neuroblastoma cells to ALA-PDTcan be related to
the high concentration of protoporphyrin IX and to the kinetics
of protoporphyrin IX accumulation in this kind of cells.
Herein, we report on the photophysics, liposome encapsu-
lation, cellular uptake, and photodynamic activity towards
human fibroblast and HeLa cells of three chlorin photosensi-
tizers derived from chlorophyll a (Fig. 1). The effect of two
administration systems, DMSO and liposomes, are compared.
Formation of singlet oxygen in the cells is unambiguously
demonstrated.
2. Materials and methods
2.1. Chemicals
L-α-palmitoyloleoylphosphatidylcholine (POPC) and L-α-dioleoyl-phos-
phatidylserine (OOPS) were purchased from Avanti Polar Lipids (Birmingham,
AL, USA). Polycarbonate membranes and imidazole were from Poretics
Products (Livermore, CA, USA) and Sigma-Aldrich Chemical Co. (St. Louis,
MO, USA), respectively. All other chemicals and solvents were of analytical
grade. Solvents have been distilled before use. Milli-Q water (Millipore
Bedford, Massachusetts system, resistivity of 18 MΩ cm) was used.
The porphyrins meso-5,10,15,20-tetraphenyl-21H,23H-porphine (TPP) and
meso-5,10,15,20-tetrakis-(4-sulfonatophenyl)-21H,23H-porphine (TPPS) were
purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO, USA) and from
Porphyrin Products (Logan, UT, USA), respectively, and were pure with a
minimal grade of 99%. Tetrahydrofuran (THF) and methylene blue (MB) of the
highest purity available were from Panreac Quimica S.A. (Barcelona, Spain).
Dulbecco's Modified Eagle's Medium with 4.5 g glucose/l (DMEM), fetal
calf serum, penicillin-streptomycin solution and L-glutamine solution for
biological assays were purchased from Biological Industries (Kibbutz Beit
Haemek, Israel). Sterile Dulbecco's phosphate-buffered saline (PBS), dimethyl
sulphoxide (DMSO) and 3-[4,5-dimethylthiazol-2-yl] 2,5-diphenyltetrazoliumFig. 1. Chemical structure of the three chlorin derivatives.bromide (MTT) were purchased from Sigma-Aldrich Chemical Co. (St. Louis,
MO, USA). The sterilized material was purchased from Techno Plastic Products
(Trasadingen, Switzerland).
The three-chlorin derivatives were prepared for this project under guidance
of Professor A. Vallès from the University of Barcelona. The synthesis followed
published methods: CHL-3 is compound 3 in reference [49] and compound 7 in
reference [50]. CHL-1 was obtained by removing the carbonyl protecting group
of compound 11 in reference [49]. CHL-2 was obtained by acid hydrolysis of
CHL-3. The structure of the compounds was verified by spectroscopy of 1H-
NMR, MS, and UV-Vis [51]. Purity of the chlorins was higher than 99.9% in all
cases.
2.2. Preparation of liposomes
Encapsulation of all the chlorin derivatives in intermediate unilamellar
liposomes (IUVs) was achieved by microemulsification following standard
procedures as previously described [41]. Briefly, POPC/OOPS mixtures
(13.5:1.5 molar ratio) at a lipid concentration of 10 or 20 mg/ml, alone or
containing the photosensitizer at 15:1 or 30:1 lipid/chlorin molar ratio,
respectively, were evaporated from a THF solution and kept in a vacuum
desiccator for 12 h over P2O5 to remove the last traces of the solvent. 50 mM
imidazole–HCl buffer (pH 7.4) was added to the dry film and the suspension
(10–20 mg lipid/ml) was stirred by vortexing for 30 min (alternating 30 s of
heating and 30 s of vortexing) at 45 °C to obtain MLVs. For singlet oxygen and
some fluorescence experiments, the dry film was hydrated with pure D2O
instead. To prepare IUVs, the MLVs dispersions were frozen and thawed (five
times), sonicated (bath sonicator, 60 min, 45 °C) and microemulsified
(EmulsiFlex B3 device, Avestin, Ottawa, Canada). Microemulsification was
carried out by pumping the fluid fifteen or thirty times through the interaction
chamber (45 °C, 200 kPa) for 10 or 20 mg lipid/ml buffer, respectively. TLC
analysis showed that the lipids did not suffer degradation during the sonication
process. The absence of free photosensitizer in the liposomal systems, after
centrifugation at 4000 rpm to eliminate the non-encapsulated dye, was checked
by ultrafiltration (Centricon YM-30 Filter Devices, Millipore, USA) and by gel
filtration (Sephadex G-50, Pharmacia Biotech, Uppsala, Sweden) of the
liposomal suspensions as described previously [41].
2.3. Spectroscopic measurements
Absorption spectra were recorded on a Varian Cary 4E spectrophotometer.
Absorption coefficients were determined from Beer–Lambert plots using at least
three independent series of experiments. Fluorescence emission spectra were
obtained using a Kontron SFM 25 fluorometer (Bio-Tek Instruments, Neufahrn,
Germany). The fluorescence quantum yields were determined by comparison of
the areas under the emission curves for optically-matched solutions of the
chlorins and a reference, after correcting for the refractive index of the solvent
(λexc=600 nm). Zinc(II) phthalocyanine was used as reference with ΦF=0.30
[52]. The absorbance of the solutions was kept below 0.05 to prevent inner-filter
effects. Fluorescence decays were recorded with a time-correlated single photon
counting system (Fluotime 200, PicoQuant GmbH, Berlin, Germany) equipped
with a red-sensitive photomultiplier. Excitation was achieved by means of a 654-
nm picosecond diode laser working at 10 MHz repetition rate. The counting
frequency was always below 1%. Fluorescence lifetimes were determined by
analysis of the data using the PicoQuant FluoFit software. The Fluotime 200 was
customized to detect the near-IR 1O2 phosphorescence in the cells using a diode-
pumped Nd:YAG laser (FTSS 355-Q, Crystal Laser, Berlin, Germany) working
at 14 KHz pulse frequency and delivering 8 mW quasi-CW power at 532 nm for
excitation. A near-IR sensitive photomultiplier tube with 300 ps TTS (H9170-
45, Hamamatsu Photonics Deutschland GmbH, Herrsching, Germany) was used
as detector. Photon counting was achieved with a Becker&Hickl (Berlin,
Germany) MSA 300 board. The quantum yields of singlet oxygen production
were determined using a 250-ns risetime Ge detector cooled at 77 K (EOL-817P,
North Coast Corp., Santa Clara, CA) to detect the 1270 nm phosphorescence
[53]. Samples were irradiated with a Continuum OPO laser (660 nm, 3 mm
beam diameter, 5 ns pulsewidth, 0.1 to 1 mJ per pulse) pumped by the 3rd
harmonic of a Continuum Surelite Nd:YAG laser. The detector output was
captured with a Lecroy 9410 digital oscilloscope, and acquired by a PC
computer for storage and analysis. Data recorded from 10 to 100 independent
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amplitude extrapolated to the end of the laser pulse was compared for the
samples and for suitable references in air-saturated, optically-matched solutions
in the same medium. Linearity of the signal amplitude with the energy of the
laser pulsed was checked. TPP with ΦΔ=0.66 [54] was used in THF, and TPPS
and MB, with ΦΔ=0.67 [55] and 0.52 [56], respectively, were used in D2O-
suspended liposomes. All spectroscopic measurements were carried out in 1-cm
quartz cuvettes (Hellma, Germany) at room temperature and, in the case of cell
suspensions, the samples were continuously stirred.
2.4. Liposome characterization
The photosensitizer content and the lipid concentration in the liposomes
were evaluated following standard procedures as described previously [41].
Liposomes were disrupted by the addition of THF to an aliquot of the liposomal
suspension, free of non-entrapped photosensitizer, obtained in imidazole–HCl
buffer (THF/imidazole–HCl buffer, 24/1, v/v) and the absorbance was measured
at the λmax of the Soret band. The photosensitizer concentration was determined
by comparison with standard curves obtained in the same conditions for each
one of the different photosensitizers. The average size and polydispersity of
unilamellar vesicles were determined by photon correlation spectroscopy (PCS)
as previously described [41].
To control the stability of the preparations, the photosensitizer and lipid
content in liposomes as well as the average size and polydispersity of the
vesicles were also determined after storage up to 336 h.
2.5. Cell cultures
Human skin fibroblast cells (Foreskin cells, ATCC CRL-1635) and human
HeLa cervical adenocarcinoma cells (ATCC CCL-2) were cultured at 37 °C in a
humidified sterile atmosphere of 95% air and 5% CO2 at 37 °C, using DMEM
supplemented with fetal calf serum (10%, v/v), glucose (4.5 g/l), L-glutamine
(292 mg/l), streptomycin sulfate (10 mg/l) and potassium penicillin (10000 U/l).
Human skin fibroblasts cells and HeLa cells were maintained frozen in DMEM
with 10% DMSO. 1.8 ml CryoTubes™ (Nunc, Nalge Nunc International, IL,
USA) were filled with the cellular suspension and then were placed in a cell
Cryo 1 °C Freezing Container (Nalgene, Nalge Nunc International, IL, USA) to
be slowly frozen up to −80 °C at a cooling rate of −1 °C/min for successful cell
cryopreservation. Frozen cells were rapidly transferred to a liquid nitrogen
container (−196 °C) and stored. Skin fibroblasts and HeLa cells are adherent
cells which grow up to form cellular monolayers toward confluence after
inoculation.
Human skin fibroblasts were seeded in 75 cm2 tissue culture flasks (Techno
Plastic Products, Trasadingen, Switzerland) and were cultured toward 80–85%
confluence in order to control the uptake of chlorin derivatives by human skin
fibroblasts. Nevertheless, to carry out cell photosensitization studies, both cell
lines were inoculated in 96-well plates at a density of 10000–15000 cells/well
and were cultured toward 90–95% confluence before beginning the experiment.
2.6. Cellular uptake
The cellular uptake of chlorin derivatives was estimated by flow cytometry,
using Foreskin cells cultured in 75 cm2 tissue culture flasks as indicated above.
Chlorin derivatives, dissolved in DMSO or incorporated into liposomes, were
added to the flasks at a concentration of 1 μM when a confluence of 80–85%
was reached and the cells were incubated with each chlorin for different periods
of time in the dark. Immediately after each time, the cells were washed with PBS
to remove the non-entrapped chlorin. Trypsinization was carried out using PBS
containing 0.2% trypsin and 0.5 mM EDTA. The suspension of cells was
centrifuged at 1500 rpm for 5 min. The pellet was suspended in PBS and prior to
flow cytometric analysis, the new suspension was filtered through nylon filters
(Nytal, 70 μm mesh, Sefar Maissa S.A., Barcelona, Spain) to exclude cellular
aggregates. Cells were analyzed for red fluorescence emission (670 nm) after
excitation at 488 nm using a MoFlo High-Speed Cell Sorter (DakoCytomation,
California, USA). The instrument was set up with the standard configuration.
The excitation of the sample was performed with a standard 488-nm air-cooled
argon-ion laser. The laser output power was set at 150 mW. Optical alignmentwas based on optimized signal from 10-nm fluorescent beads (Immunocheck,
Epics Division, Coulter, FL, USA). Time was used as a control of the stability of
the instrument. Red fluorescence was projected on a 1024 mono-parametrical
histogram.
2.7. Cell photosensitization studies
Fibroblasts and HeLa cells were seeded in 96-well plates as indicated above
and, when cell monolayers had reached a 90–95% confluence, the wells were
inoculated with the appropriate amount of each chlorin derivative to obtain a
photosensitizer concentration ranging from 1 to 10 μM in the wells. The cells
were incubated for 1 or 24 h in the dark with the chlorins dissolved in DMSO or
incorporated into liposomes. The cells were washed with PBS to remove non-
entrapped chlorin and finally the buffer was replaced by the culture medium,
supplemented as indicated above. Cell monolayers were then irradiated in
DMEM for 36 min and 22 s, using a LED illuminator at 660 nmwith a fluence of
7.2 J/cm2.
The light dose and chlorin concentrations used in the phototoxicity studies
were chosen on the basis of previous experiments, where the toxicity of the
photodynamic treatment with different photosensitizers, among them CHL-1,
towards red blood cells was assessed, bearing in mind that the administration
route of our liposomal formulations would be the intravenous route [57]. Thus,
the influence of the light dose and the photosensitizer concentration on red blood
cells parameters after PDT was determined both in whole blood and red blood
cells concentrates. In this way, experiments using CHL-1 concentrations ranging
from 0.5 to 38 μM and light fluences of 1.4, 7.2, 14.4 and 21.6 J/cm2 were
carried out. The data obtained showed that a CHL-1 concentration up to 20 μM
and a fluence up to 7.2 J/cm2 will assure the integrity of red blood cells.
According with this observation, we used the above mentioned chlorin
concentrations of 1 μM to 10 μM and a fluence of 7.2 J/cm2 to carry out the
experiments reported in this paper.
After irradiation, the cells were incubated in the dark for different periods of
time (0, 1, 2 and 24 h) before each assessment. The phototoxicity was next
determined by the MTT colorimetric assay [58]. The cells were washed with
PBS and 200 μl of DMEM, containing 2 mg MTT/ml, were added to each well.
After 2-h incubation in the dark at 37 °C, the MTT solution was replaced by
DMSO. The plate was finally vortexed for 10 min on a shaker and the
absorbance at 550 nm was read on an ELISA microplate reader (ELISA System
MIOS, Merck, Darmstadt, Germany). Photosensitization experiments were
performed in triplicate and the samples without photosensitizers were used as
negative controls. All experiments were performed in the dark to avoid
unspecific photodynamic inactivation. The rate of phototoxicity was calculated
as follows:
% MTT bioreduction ¼ Abssample  Absbackground
Abscontrol  Absbackground  100 ð1Þ
where Abssample, Absbackground and Abscontrol refer to the absorbance of the
sample, the absorbance of the background (wells without cells) and the
absorbance of the control (wells without photosensitizers), respectively.3. Results
3.1. Photophysical properties of chlorins in solution
The photophysical properties of the photosensitizers were
first determined in THF solutions in order to establish the basic
properties of the compounds. Chlorins used in this work display
a strong absorption band around 410 nm (the Soret band) and a
series of weaker single Q bands in the 450–700 nm region of the
visible spectrum (Fig. 2). Of specific interest for PDT, the
lowest-energy band in the Q region, located around 660 nm, is
also the strongest one with absorption coefficient ca. 4×104
M−1 cm−1, 10-fold higher than those of porphyrins. These are
typical features of chlorin photosensitizers [59]. The ratio
Fig. 2. Absorption spectra of 2.5 μM chlorin derivatives in THF ( ) and in a
suspension of POPC/OOPS liposomes ( ). The molar ratio of lipid/chlorin was
15:1 for CHL-1 and CHL-2, and 30:1 for CHL-3.
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concentration assayed, 100 μM, indicating that the chlorin
derivatives are in monomeric form in this solvent. The addition
of lipids caused a small but significant increase in the absorption
coefficients (Table 1).
The fluorescence emission spectra show one intense
band overlapping strongly with the lowest-energy absorption
band and a smaller shoulder at ca. 710 nm (Fig. 3). The
shape of the emission spectrum was independent of the
excitation wavelength, consistent with the chlorin deriva-
tives being present in monomeric form in THF solutions in
agreement with the absorption-spectroscopy results. The
area under the fluorescence spectrum for optically-matched
solutions of the three chlorins was nearly identical,
indicating that the fluorescence quantum yield is indepen-
dent of the sensitizer structure. The fluorescence quantum
yields compare favorably to values published for closely-
related compounds [60]. The fluorescence decay of the
three chlorins was strictly monoexponential in THF, with
lifetime 6.9 ns, also independent of the sensitizer structure
(Table 1 and Fig. 4).The three compounds are able to sensitize the photoproduc-
tion of 1O2 (Fig. 5). The quantum yield of
1O2 photogeneration
is close to 0.6, once again essentially independent of the
sensitizer structure (Table 1). This value is typical for chlorin
photosensitizers [61]. Overall, the photophysical properties of
the three chlorins fulfill the requirements for a PDT
photosensitizer.
3.2. Characterization of chlorin-loaded liposomes
The photosensitizer concentration in the liposomal systems
was estimated spectrophotometrically, as indicated in Liposome
characterization, using for each chlorin derivative the absorp-
tion coefficient (Soret band) obtained in THF solutions at the
same lipid/photosensitizer molar ratio (Table 1).
Table 2 gives the incorporation efficiency for the different
chlorin derivatives. The values at time 0 correspond to the
lipid and chlorin content of freshly-prepared liposomal
systems, whereas the values at 24, 168 and 336 h were
determined to control the stability of the liposomal systems
during storage. The data indicate that the incorporation
efficiency of CHL-1 and CHL-2 into POPC/OOPS liposomes
was near 100%, resulting in a final concentration of
8.7×10− 4 M in the liposomal/buffer suspension. This
concentration is ca. 10-fold higher than that used in typical
liposome formulations [33,62]. While this affects the photo-
physical behavior of the chlorins in the liposomes (see below),
we nevertheless favored this approach keeping in mind that an
eventual pharmaceutical formulation should minimize the
volume to be injected into a living organism. However, the
percentage of incorporation obtained for CHL-3 was lower
(70%, 6.1×10−4 M final concentration). On the other hand,
the lipid content, expressed as the percentage of lipid in the
sample relative to the lipid amount at the initial stage of the
liposome preparation, was near 100% (ca. 10 mg lipid/ml
liposomal dispersion), irrespective of the chlorin derivative
used, thus preserving the 15:1 lipid/chlorin ratio for CHL-1
and CHL-2, and increasing it to 23:1 for CHL-3. These results
indicate that there is a hindrance for the incorporation of
CHL-3 into liposomal bilayers.
After 336 h storage, both the lipid and chlorin contents
remained almost constant (>94%) in all cases, indicating that
the liposomal dispersions are highly stable. Moreover, the
liposomes containing CHL-3 are as stable as those containing
CHL-1 and CHL-2 despite the lower incorporation efficiency of
this chlorin.
Liposomes containing the three-chlorin derivatives at 15:1
lipid/photosensitizer molar ratio were also analyzed for average
size and polydispersity by dynamic light scattering. The results,
summarized in Table 2, show that the mean hydrodynamic
diameter for the three liposomal systems was almost the same
and remained constant during storage (135±12 nm). Thus, the
nature of the photosensitizer does not modify the mean size of
the vesicles. The results also confirm the stability of the
liposomal systems. The polydispersity values, ranging from
0.25 to 0.40, are typical of the microemulsification method used
to obtain the liposomes, which, in general, provides liposomal
Table 1
Photophysical properties of the chlorin photosensitizers in THF, POPC/OOPS liposomes, and human skin fibroblasts
Compound CHL1 CHL2 CHL3
Sample THF Liposomes Fibroblasts THF Liposomes Fibroblasts THF Liposomes Fibroblasts
λmax
abs (Q-reg) (nm) 657 661 – 656 661 a – 656 662a –
εmax (Soret) (M
−1 cm−1) 95400 – – 96300 – – 110000 – –
97000 (L) b 99000(L)b 115000(L)b
120000(2L)b
εmax (Q) (M
−1 cm−1) 42400 – – 43300 – – 43700 – –
λmax
flu (nm) 657 661 – 656 660 – 656 658 –
ΦF 0.45 0.13 – 0.42 0.13 – 0.47 0.24 –
ΦF/ΦF (THF) 1 0.28 – 1 0.32 – 1 0.52 –
τflu (ns) 6.9 3.5
c,d, 1.3c,e 7.3 6.9 3.6c,d, 0.8c,e 7.3 6.9 6.7c,d, 1.9c,e 7.4
ΦΔ 0.63 0.18
f – 0.65 0.19f,g – 0.59 0.32f –
ΦΔ/ΦΔ (THF) 1 0.29 – 1 0.29 – 1 0.54 –
λmax
abs , wavelength of maximum absorption (±1 nm); εmax, absorption coefficient at the maximum (±5%); λmax
flu , wavelength of maximum fluorescence (±1 nm); ΦF,
fluorescence quantum yield (±10%); τflu, fluorescence lifetime (±5%); ΦΔ, quantum yield of singlet oxygen production (±20%).
a Appears red shifted due to scattering.
b The absorption coefficient increases slightly upon addition of lipids at a chlorin/lipid ratio 1:15 (L) and 1:30 (2 L).
c Average lifetimes (see Table 3).
d In unbuffered H2O.
e In 50 mM imidazole/HCl buffer (pH 7.4).
f In unbuffered D2O.
g The same result was observed in POPC liposomes.
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extrusion.
In order to increase the amount of CHL-3 incorporated
into the liposomal system, the amount of lipid was doubled.
Thus, with a lipid concentration in the liposomal dispersion
of 20 mg lipid/ml and an initial lipid/CHL-3 molar ratio of
30:1, the incorporation efficiency of CHL-3 increased to
97%. The lipid content, expressed as the percentage of lipid
in the sample relative to the lipid amount at the initial stage
of the liposome preparation, was near 100%, hence the lipid/
CHL-3 molar ratio in the freshly-prepared liposomal systems
was close to 30:1. The mean hydrodynamic diameter was
145±15 nm and remained almost constant after 336 h of
storage (141±17 nm), showing again the stability of this new
liposomal system.
In summary, the three chlorins have been quantitatively
incorporated into liposomes, though CHL-3 required a double
amount of lipid. The size of the liposomes is essentially
independent of the chlorin nature and the suspensions are stable
over long periods of time, allowing their storage.
3.3. Effect of liposome incorporation on the photophysical
properties of chlorin derivatives
Incorporation of the chlorins into liposomes produced
remarkable changes in their photophysical properties. The
Soret and Q bands decreased their intensity and shifted slightly
to the red. In the case of CHL-1, a shoulder appeared at the red
end of the spectrum (Fig. 2).
Consistent with the changes in the absorption spectra,
the fluorescence intensity decreased significantly for the
three compounds. The fluorescence quantum yield of the
chlorins in liposomes prepared in D2O was, relative to itsvalue in THF solution, 0.28, 0.32, and 0.54 for CHL-1,
CHL-2, and CHL-3, respectively (Fig. 3). Likewise, the
fluorescence decay kinetics showed a more complex pattern
than in THF solutions. Thus, two to three exponential
terms were needed to fit the fluorescence decay data (Fig.
4 and Table 3) and the average fluorescence lifetime was
shorter than in THF. Moreover, it was shorter for CHL-1
and CHL-2 than for CHL-3 (Table 1). It is worth noting
that the nature of the medium employed for the hydration
of the lipid-chlorin film in the liposome preparation has
additional effects on the fluorescence kinetics. Thus, when
the aqueous phase contained imidazole/HCl 50 mM, the
lifetimes decreased further relative to neat D2O or
phosphate buffer.
The lower fluorescence intensity and faster decay of the
chlorins' singlet excited state in the vesicles suggests that they
should produce singlet oxygen with lower efficiency than in
THF solution. This is indeed the case (Fig. 5 and Table 1) and
the ratios ΦΔ (liposomes)/ΦΔ (THF) are in excellent agreement
with the ratios ΦF (liposomes)/ΦF (THF) values for the three
chlorins (Table 1).
While the changes in the absorption spectrum could be
attributed to the lipid environment [41], the decrease of the
fluorescence and singlet oxygen quantum yields, and the
complex fluorescence decay kinetics are likely the consequence
of the high local concentration of the chlorins in the lipid
bilayers (ca. 70 mM, roughly 4000-fold larger than in THF)
[63], as suggested by similar observations for related macro-
cycles in lipid bilayers [42,64,65]. It is particularly revealing
that CHL-3, with a lower 1:30 chlorin-to-lipid ratio, is clearly
less affected (Fig. 2), even though it is possible that this
differential behavior reflects a different site of localization
within the lipid bilayer [35].
Fig. 4. Fluorescence decay of 16.45 μM chlorin derivatives in THF ( ), in a
suspension of POPC/OOPS liposomes ( ), and in a suspension of human skin
fibroblasts ( ). The molar ratio of lipid/chlorin in the liposomes was 15:1 for
CHL-1 and CHL-2 and 30:1 for CHL-3. Samples were excited at 654 nm and
fluorescence was observed at 660 nm.
Fig. 3. Fluorescence spectra of 2.5 μM chlorin derivatives in THF ( ) and in a
suspension of POPC/OOPS liposomes ( ). The molar ratio of lipid/chlorin in
the liposomes was 15:1 for CHL-1 and CHL-2 and 30:1 for CHL-3. Samples
were excited at 600 nm.
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The incorporation of chlorin derivatives into human skin
fibroblasts was measured by flow cytometry. Fig. 6 shows the
fluorescence of the cells as a function of the incubation time.
The chlorin uptake increases steadily, reaching a higher plateau
level for CHL-1 than for CHL-2, and this one in turn slightly
higher than for CHL-3. This differential behavior is observed
irrespective of the vehicle used to deliver the chlorins, DMSO
or liposomes. For any given chlorin, a higher uptake is observed
when the photosensitizers are solubilized in DMSO (cf. Fig. 6A
and B).
3.5. Chlorin photophysics in human skin fibroblasts
Because of its unparalleled sensitivity, fluorescence spec-
troscopy is the ideal tool to examine the behavior of the chlorins
incorporated into fibroblasts. As shown in Fig. 4 and Table 1,
the behavior of chlorins in the cells is closer to that in THFsolution than to that in liposomes. Thus, the fluorescence decays
are strictly monoexponential, with lifetimes slightly higher than
in THF solution, indicating that the chlorins exist as isolated
monomer species in the cells and that they experience a similar
environment.
The delivery vehicle, DMSO or liposomes, has no influence
whatsoever on the fluorescence results (data not shown). It may
thus be expected that the properties observed in THF hold in the
cellular environment. Specifically, we would expect the chlorins
to act as good singlet oxygen sensitizers. Indeed, using an
ultrasensitive singlet oxygen detection system we were able to
record the phosphorescence of singlet oxygen at 1270 nm
generated by cell-incorporated chlorins (Fig. 7). Thus, a signal
is observed at 1270 nm growing with time constant 3.3 μs and
decaying with lifetime 3.7 μs. The decay lifetime is close to the
reported lifetime value for 1O2 in H2O, suggesting that
1O2 is
Fig. 5. Time-resolved 1270-nm 1O2 phosphorescence photosensitized by
optically-matched solutions of the chlorins and a reference sensitizer excited
at 660 nm. A monoexponential function could appropriately fit the decay part of
the transient (dashed line superimposed). The intensity at time = 0 (marked) is
proportional to the 1O2 quantum yield. (A) Decays in THF. The reference is TPP,
with ΦΔ = 0.68. (B) Decays in D2O suspensions of POPC/OOPS liposomes. The
molar ratio of lipid/chlorin in the liposomes was 15:1 for CHL-1 and CHL-2 and
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those observed for triplet sensitizers in cellular environments
[17].
In order to validate our interpretation of the signal the
following control experiments were carried out. First, the
luminescence was recorded at 1150 nm, where 1O2 does not
emit. At this wavelength, the signal disappeared, which confirms
that the signal at 1270 nmwas indeed caused by 1O2. Second, we
centrifuged the cells and analyzed the supernatant fluid at
1270 nm. No signal could be observed either, confirming that the
signal at 1270 nm was caused by 1O2 generated within the cell
and not in the extracellular aqueous phase by a chlorin molecule
that might had leaked from the cell [17].
Thus, the chlorins are able to photosensitize the production
of 1O2 in the fibroblasts and it can thus be expected that they
will be able to photosensitize damage to these cells.
3.6. Photosensitization experiments of human skin fibroblasts
Studies on cell-photosensitization efficiency are summarized
in Fig. 8. Human skin fibroblasts were treated with the chlorin
derivatives either solubilized in DMSO or incorporated into
POPC/OOPS liposomes. The cells were incubated with 1 μM
chlorins for 1 or 24 h in the dark prior to photosensitization.
Afterwards, the cells were exposed to red light using a LEDilluminator at 660 nm with a fluence of 7.2 J/cm2. The
phototoxicity for human skin fibroblasts was assessed by the
MTT assay at different post-irradiation times. It was observed
that chlorin phototoxicity increased upon irradiation, as could
be expected from the observed formation of singlet oxygen.
Moreover, the chlorin nature, delivery vehicle, length of the pre-
incubation period, and post-irradiation time affected cell
photoinactivation in specific ways. Irrespective of the delivery
vehicle used, all the chlorins were non-toxic in the dark (data
not shown).
When cells were incubated with the chlorins for 1
h before irradiation (Fig. 8A and C), CHL-1 showed the
highest photodynamic activity, irrespective of the delivery
vehicle used and of the post-irradiation time. In all cases the
order of effectiveness was CHL-1 ≫ CHL-2>CHL-3, with
cell photoinactivation as high as 95% for CHL-1 24 h after
irradiation. For any given chlorin, the nature of the delivery
vehicle had no influence on the 24 h phototoxicity;
however, DMSO-delivered chlorins were more effective at
early times.
In all cases, cell damage appeared earlier in cells incubated
with the chlorins for 24 h (Fig. 8B and D) than in cells
incubated with the sensitizers for only 1 h (Fig. 8A and C). In
general, the extension and the rate of cell damage increased
drastically when fibroblasts were incubated with the chlorins
for 24 h before irradiation (Fig. 8B and D), consistent with the
higher uptake of the drug (Fig. 6). The three chlorins were
almost equally effective at inducing cell damage, irrespective
of the delivery vehicle, as demonstrated by the similar
phototoxicity observed 24 h after irradiation (see the 24-h bars
in Fig. 8B and D; the only exception is CHL-2 in DMSO). In
spite of the similar final phototoxicity, the time evolution of
MTT bioreduction showed substantial differences among the
photosensitizers and delivery vehicle used. Thus, in liposomes
(Fig. 8B), CHL-1 caused almost complete damage immedi-
ately after irradiation, while for CHL-3, and especially for
CHL-2, MTT bioreduction decreased more slowly. However,
when DMSO was used, CHL-1 and CHL-3 showed a similar
photodamage evolution, which was much faster than for CHL-
2 (Fig. 8D). The incubation time before irradiation had a
significant effect only on time evolution of the phototoxicity
for CHL-3, when DMSO was used as delivery vehicle (see the
CHL-3 bars in Fig. 8C and D).
3.7. Comparative photodynamic effects on human skin
fibroblasts and HeLa cells
The photodynamic activity of CHL-1 was comparatively
studied in two cell lines, human skin fibroblasts and HeLa
cervical adenocarcinoma cells. The cells were incubated with
different amounts of CHL-1 incorporated into POPC/OOPS
liposomes for 1 h in the dark. Afterwards, the cells were
exposed to red light using a LED illuminator at 660 nm with
a fluence of 7.2 J/cm2. Cell phototoxicity was assessed by
the MTT assay 24 h after irradiation. The chlorin was
ineffective in the dark irrespective of the cell line used (data
not shown).
Fig. 6. Chlorin derivatives uptake by human skin fibroblasts. Human skin
fibroblasts were incubated between 30 and 1440 min with CHL-1 (●), CHL-2
(■) and CHL-3 (▴) at 1 μM in the dark. Chlorin derivatives were added to the
incubates incorporated into POPC/OOPS liposomes (A) or dissolved in DMSO
(B). The molar ratio of lipid/chlorin was 15:1 for CHL-1 or CHL-2 and 30:1 for
CHL-3. At different periods of time, cells were washed with PBS, trypsinized
and centrifuged. The pellet was suspended in PBS and the cells were analyzed
by flow cytometry. The transient increase in intracellular chlorin was recorded
by monitoring the change in red fluorescence emission of the cells after
excitation at 488 nm as a function of the incubation time with chlorins in the
dark. Fluorescence change corresponds to the ratio between the fluorescence
counts for each sample and for the control (without chlorins). Uptake
experiments were performed in triplicate and CV values ranged from 4 and 16%.
Table 2
Incorporation efficiency of chlorins in POPC/OOPS liposomes and stability of
the liposomal systems
Sample Time (h) CHLa (%) [CHL] (Molar) Zave b
POPC/OOPS/CHL-1
(13.5:1.5:1)
0 96±2.0 (8.6±0.2)×10−4 123±28
24 93.0±3.2 (8.4±0.3)×10−4 123±15
168 93.7±3.0 (8.5±0.3)×10−4 128±7
336 93.2±2.3 (8.4±0.2)×10−4 128±6
POPC/OOPS/CHL-2
(13.5:1.5:1)
0 98.7±2.0 (8.7±0.2)×10−4 135±25
24 96.3±2.1 (8.5±0.2)×10−4 142±17
168 94.3±3.7 (8.3±0.2)×10−4 139±6
336 95.0±1.3 (8.4±0.1)×10−4 129±7
POPC/OOPS/CHL-3
(13.5:1.5:1)
0 70.4±4.8 (6.1±0.4)×10−4 145±17
24 72.1±3.0 (6.2±0.5)×10−4 132±17
168 69.0±1.8 (5.9±0.2)×10−4 126±5
336 65.8±2.6 (5.7±0.2)×10−4 128±9
POPC/OOPS/CHL-3
(27:3:1)
0 100±1.0 (8.2±0.1)×10−4 142±24
24 95.9±3.1 (7.9±0.2)×10−4 140±19
168 97.2±2.8 (8.1±0.2)×10−4 135±10
336 95.5±1.2 (7.8±0.1)×10−4 133±7
Liposomes were obtained in a 50 mM imidazole–HCl buffer (pH 7.4) at a lipid
concentration of 10–20 mg/ml. The lipid/chlorin molar ratios, indicated in the
table, were those used for liposome preparation.
a CHL: Chlorin derivative content, expressed as the percentage of the chlorin
derivative in the sample with respect to the photosensitizer present at the initial
stage of liposome preparation.
b Z average mean calculated from photon correlation spectroscopy data. Data
are the mean values ± S.D. of three independent experiments.
591F. Postigo et al. / Biochimica et Biophysica Acta 1758 (2006) 583–596Photodynamic treatment resulted in extensive cell death for
both cell lines. Fig. 9 shows the cell phototoxicity as a function
of the CHL-1 concentration. As can be observed, the LD50 in
HeLa cells (2 μM) is ca. 5-fold higher than in human skin
fibroblasts (0.4 μM). Moreover, the concentration of CHL-1
needed to decrease the MTT bioreduction of HeLa cells below
5% is 10 μM, 10-fold higher than that needed to produce the
same damage to fibroblasts.
4. Discussion
The photodynamic effect has been extensively studied and
its therapeutic benefits have been clinically proved [2–12].
From a pharmaceutical point of view, the chemical nature of the
sensitizer [11] and its selective uptake by malignant cells
[30,33,35,37–39] must be taken into account when choosing an
appropriate biocompatible carrier. The present paper reports on
the study of the potential of three chlorins, derived from
chlorophyll a, for photodynamic therapy as well as on the
usefulness of their incorporation into liposomes in order toTable 3
Fluorescence decay in liposome suspensions. The fluorescence intensity I(t) was fitt
Sample CHL1 CHL2
Fluorescence decay lifetimes τ1/ns (A1/%) τ2/ns (A2/%) τ3/ns (A3/%) τ1/ns (A
POPC/OOPS liposomes
in unbuffered H2O
4.4 (67%) 1.6 (33%) – 4.7 (65%
POPC/OOPS liposomes
in imidazole/HCl buffer
2.3 (17%) 0.9 (41%) 0.2 (42%) 1.8 (5%obtain a colloidal biocompatible carrier for pharmaceutical
formulations.
The three chlorins assayed (CHL-1, CHL-2 and CHL-3)
have been quantitatively incorporated into POPC/OOPS
liposomes, though CHL-3 required a double amount of lipid
(20 mg lipid/ml) than CHL-1 and CHL-2 (10 mg lipid/ml). The
size of the liposomes is essentially independent of the chlorin
nature and the suspensions are stable over long periods of time,
allowing their storage. The final concentration of the chlorins in
the liposomal/buffer suspensions was, in all cases, near
8.0×10−4 M, which is ca. 10-fold higher than that used in
typical liposome formulations [33,62]. This increase in the
sensitizer concentration should minimize the volume to be
injected into a living organism from an eventual pharmaceutical
formulation.
The area under the fluorescence spectrum for optically-
matched solutions in THF of the three chlorins was nearly
identical and the fluorescence decay of the three chlorins wased to the equation IðtÞ ¼Pi Aiexpðt=siÞ
CHL3
1/%) τ2/ns (A2/%) τ3/ns (A3/%) τ1/ns (A1/%) τ2/ns (A2/%) τ3/ns (A3/%)
) 1.7 (35%) – 7.3 (89%) 2.1 (11%) –
) 0.6 (39%) 0.2 (56%) 3.7 (23%) 1.8 (49%) 0.5 (28%)
Fig. 7. Time-resolved 1O2 phosphorescence from an H2O-suspension of human
skin fibroblasts loaded with CHL-1. The chlorin was excited at 532 nm. (A)
Emission wavelength set at 1270 nm. A signal is clearly visible with rise-time
3.3 μs and decay-time 3.7 μs, consistent with 1O2 located mainly in an aqueous
environment. (B) Emission wavelength set at 1150 nm. The slow signal has
disappeared, consistent with the lack of phosphorescence of 1O2 at this
wavelength. This confirms the assignment of the 1270-nm signal to 1O2. (C)
Emission wavelength set to 1270 nm. The cell suspension has been centrifuged
and the supernatant, extracellular aqueous phase is now analyzed. The absence
of signal demonstrates that 1O2 was produced in the cell and was able to diffuse
to the external aqueous phase within its lifetime.
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Moreover, the three compounds are able to sensitize the
photoproduction of 1O2 (Fig. 5), with a quantum yield for
1O2
photogeneration close to 0.6, (Table 1), which is typical for
chlorin photosensitizers [60]. These results show that, in THF
solution, the fluorescence quantum yield, the fluorescence
decay and the 1O2 photogeneration quantum yield are
essentially independent of the sensitizer structure and indicate
that the photophysical properties of the three chlorins fulfill the
requirements for a PDT photosensitizer.
The incorporation of the chlorins into liposomes produced
remarkable changes in their photophysical properties. Thus, the
Soret and Q bands decreased their intensity and shifted slightly
to the red, the fluorescence intensity decreased significantly for
the three compounds and the fluorescence decay kinetics
showed a more complex pattern than in THF solutions. Two to
three exponential terms were needed to fit the fluorescence
decay data obtained for chlorins incorporated into liposomes
(Fig. 4 and Table 3) and the average fluorescence lifetimes in
liposome-buffered suspensions were shorter than in THF (Table
1). Moreover, liposomal-trapped sensitizers produce singletoxygen with lower efficiency than in THF solution. While the
changes in the absorption spectrum of chlorins incorporated into
liposomes could be attributed to the lipid environment [41], the
decrease of the fluorescence and singlet oxygen quantum yields,
and the complex fluorescence decay kinetics are likely the
consequence of the high local concentration of the chlorins in
the lipid bilayers as suggested by similar observations for
related macrocycles in lipid bilayers [42,64,65]. An estimation
for such concentration can be made by assuming that the
volume occupied by one molecule of lipid is roughly
0.5 nm2×3 nm=1.5 nm3. Thus, the chlorin:lipid ratio 1:15
corresponds roughly to a concentration of 1 molecule of chlorin
per 23 nm3 of lipid environment or ca. 70 mM, 4000-fold larger
than in THF.
The chlorin uptake by skin fibroblasts increases steadily,
reaching a higher plateau level for CHL-1 than for CHL-2, and
this one in turn slightly higher than for CHL-3. Moreover,
irrespective of the chlorin nature, the uptake was higher when
the sensitizer was added to the flask cultures dissolved in
DMSO than incorporated into liposomes. These results agree
with the faster intake of other photosensitizers by mouse tissues
[66] or by Jurkat cells [67] when DMSO was used as delivery
vehicle instead of liposomes. Wang et al. [66] showed that for a
specific tissue the initial sensitizer intake was higher when its
administration was carried out from a DMSO solution, as we
observe in our cell cultures. Rancan et al. [67] indicate that, in
general, sensitizers delivered in liposomes reach lower
intracellular concentrations than those delivered in ethanol or
DMSO solutions. On the other hand, the higher uptake of CHL-
1 relative to CHL-3 is in line with the results obtained by
Rancan et al. working with other chlorins [67], which showed
that the most amphiphilic dye, with the highest affinity for
hydrophilic/hydrophobic interfaces, exhibits the best uptake
according to its higher ability to pass easily through the
phospholipid bilayer. The lower uptake for the polar anionic
chlorin CHL-2 can be attributed to the electrostatic barrier
created by the negative membrane potential.
It could seem that DMSO solutions should be preferred over
liposome suspensions as delivery vehicles in view of the
negative effects of liposomes on the photophysical properties of
the sensitizers and on their cellular uptake. However, solutions
containing more than 30% DMSO are not pharmaceutically-
acceptable formulations and such concentration is not enough
yet to solubilize our hydrophobic chlorins. In contrast,
liposomes are biocompatible and the high chlorin concentration
(0.4 mg/ml) achieved by us makes them attractive for
pharmaceutical purposes. For comparison, Photofrin is admin-
istered at 2.5 mg/ml. Indeed, verteporfin, a hydrophobic
photosensitizer currently marketed under the trade name
Visudyne, is formulated as a liposomal suspension [18,68].
Moreover, Wang et al. [66] reported a higher exclusion of the
hypocrellin A sensitizer out of the tissue when DMSO was used
relative to liposome formulations, concluding that liposomal
formulations increase the sensitizer amount in tumor tissues
and, as a consequence, achieve higher tumor regression. A third
point to consider is that the chlorins exist as monomers in the
cells, as demonstrated by the same photophysical properties as
Fig. 8. Photosensitization efficiencies of chlorin derivatives in POPC/OOPS liposomes (A, B) and in DMSO (C, D) measured by the MTT assay. CHL-1 ( ), CHL-2
( ) and CHL-3 ( ) were added to the wells at 1 μM. The molar ratio of lipid/chlorin derivative was 15:1 for CHL-1 and CHL-2, and 30:1 for CHL-3. After
incubation for 1 h (A, C) or 24 h (B, D) in the dark with the chlorins, cell monolayers were irradiated at 660 nm with a fluence of 7.2 J/cm2. After irradiation, cells were
maintained in the dark for 0, 1, 2, and 24 h before each assessment. Samples containing chlorin-free POPC/OOPS liposomes (A, B) or neat DMSO (C, D) were used as
negative controls (▭). Photosensitization experiments were performed in triplicate and the CV values ranged from 8 to 20%.
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chlorins in the liposome bilayer does not negatively affect their
photosensitizing ability, nor predetermine their behavior in the
cells. As such, the choice of liposomes as carriers would have
the additional benefit of a lower phototoxicity of the circulating
photosensitizer, given the lower singlet oxygen yields when
incorporated in the liposome bilayers with high chlorin-to-lipid
molar ratio. This is a desirable feature of a pharmaceutical
formulation in order to reduce the risk of side effects.
Using an ultrasensitive singlet oxygen detector, we have
been able to record the dynamics of singlet oxygen phospho-Fig. 9. Comparative photodamage of fibroblasts and HeLa cells after CHL-1-
mediated photodynamic treatment. Cells were incubated in the dark for 1 h with
different amounts of POPC/OOPS liposomal suspensions either loaded with
CHL-1 (▵,▴) or empty (○,●). Fibroblasts (○,▵) and HeLa cell monolayers
(●,▴) were irradiated at 660 nm with a fluence of 7.2 J/cm2. MTT bioreduction
percentage was measured 24 h after irradiation. Photosensitization experiments
were performed in triplicate and the CV values ranged from 8 to 20%.rescence at 1270 nm photosensitized by the chlorins in the
fibroblasts. Given the high reactivity of singlet oxygen towards
biomolecules, it can be expected that the chlorins will be able to
photosensitize damage to these cells. As a side result, it is
interesting to note that singlet oxygen, formed in the cell
membrane, is indeed able to escape into the external aqueous
phase. This probably means that the chlorins are located very
near to the water–lipid interface, not surprising given their polar
side chains.
Irrespective of the delivery vehicle used, all the chlorins were
non-toxic in the dark but produced extensive cell damage under
photodynamic conditions. The efficiency of cell photosensiti-
zation depended on the nature of the chlorin and on the cell line,
the delivery vehicle, and the length of the pre-incubation period
and post-irradiation time. CHL-1 proved the most effective
compound, irrespective of the treatment conditions. The
photodynamic behavior observed for the three chlorins reflects
their relative cellular uptake, which in turn is determined by the
nature of their peripheral side chains. Thus, the moderately
polar, non-ionic compound CHL-1 shows the highest uptake
(Fig. 6) and the highest photodynamic activity (Fig. 8). The
negative charge on CHL-2 and the higher hydrophobicity of
CHL-3 could account for their lower incorporation into the cells
and lower photodynamic efficiency. The effect of the delivery
vehicle is best revealed by comparing the efficiency of cell
killing by the chlorins incubated for different periods of time.
Thus, when the sensitizers were pre-incubated for 1 h, DMSO-
delivered chlorins were more effective than liposome-delivered
ones. These results agree with the faster uptake of chlorins
delivered in DMSO and with observations with other sensitizers
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vanished when the chlorins were pre-incubated for 24 h, and
the overall efficiency of cell killing increased. It would seem
that the higher uptake of DMSO-delivered chlorins does not
translate into higher photodynamic efficiency, probably as a
result of a different subcellular localization pattern.
Finally, the photodynamic activity of CHL-1 against two
different cell lines was compared. In addition to the efficiency
against human skin fibroblasts, CHL-1 was also highly efficient
against the cervical adenocarcinoma HeLa cells, although the
LD50 in HeLa cells (2 μM) was ca. 5-fold higher than in human
skin fibroblasts (0.4 μM). These results are in line with those of
other sensitizers [47] and reflect the high resistance of HeLa
cancer cells [45]. On the other hand, Namiki et al. [69], working
with the lipophilic chlorin Ce6 trimethyl ester incorporated in
PEG-stealth liposomes and nine kinds of gastric cancer cell
lines, obtained values of LD80 ranging from 1.9 to 27 μM,
which are in line with the LD80 values of 0.45 or 4.45 μM
obtained by us working with the chlorin CHL-1 and fibroblasts
or HeLa cancer cells under similar conditions. Besides, they
reported that the LD80 values of the Ce6 trimethyl ester
incorporated in PEG-stealth liposomes were approximately 50
times smaller than those corresponding to the Ce6 sodium salt,
without liposomes. Moreover, the nature of the liposomal
carrier is also important since Ichikawa et al. showed that
PGEylation enhances the passive targeting of liposomal BDP-
MA (benzoporphyrin derivative monoacid) in tumor, but
decreases the susceptibility of the drug in PDT [70]. This fact
has been taken into account in the design of our liposomal
formulations.
In summary, we have established a protocol to incorporate
almost quantitatively chlorin photosensitizers into liposomes at
concentrations 10-fold larger than in typical formulations.
While liposome encapsulation induces important changes in the
photophysical properties of photosensitizers, a likely conse-
quence of the high local concentration of the chlorins in the
bilayers, it does not impair their cellular uptake or their cell
photosensitization ability. In fact, we have observed in the cells
the same photophysical behavior as in THF solution. Specif-
ically, we have demonstrated, by recording the near-IR
phosphorescence of 1O2, that the chlorins are able to
photosensitize the production of 1O2 in the cell membrane.
The high photodynamic activity of chlorin-loaded liposomes on
a fibroblasts cell model, together with the ability to prepare
liposome suspensions containing high chlorin concentrations
and the possibility to design liposomal carriers to achieve a
specific target site, favors the use of this approach for the
extension of these studies to in vivo tumor models as a means to
assess the therapeutic efficacy of our formulations.
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